🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized controlled trial to evaluate the efficiency of serum tears mad...
Status
Withdrawn
Location
Toyos Clinic
Start Date
2021-12-01
Trial ID
NCT03286166
Background: Sickle cell disease (SCD) is an inherited disorder of the bloo...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-05-12
Trial ID
NCT05357482
Treatments Being Tested
This is a single institution phase I/II study using an ADAM17 inhibitor (IN...
Status
Completed
Location
University of Minnesota Medical Center, Fairview
Start Date
2014-05
Trial ID
NCT02141451
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Unknown
Location
Medizinische Klinik, Klinikum Augsburg
Start Date
2005-06
Trial ID
NCT00397800
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-08
Trial ID
NCT01421173
Phase I/II clinical trial on the per-operative intra-tumoral administration...
Status
Active Not Recruiting
Location
Universitair Ziekenhuis Brussel
Start Date
2016-11-17
Trial ID
NCT03233152
This phase Ib trial studies whether anti-CD19-chimeric antigen receptor (CA...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2016-11-15
Trial ID
NCT02706405
The goal of this clinical research study is to see if high-dose chemotherap...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-09
Trial ID
NCT01538472
Treatments Being Tested
This phase II study is designed to determine the clinical efficacy of PD-1 ...
Status
Recruiting
Location
National Research Oncology Center
Start Date
2024-01-09
Trial ID
NCT06812858
Treatments Being Tested
RATIONALE: Lenalidomide may stop the growth of cancer by blocking blood flo...
Status
Terminated
Location
Fairview Cancer Hospital
Start Date
2010-01
Trial ID
NCT01045928